Psychoactive Drugs Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psychoactive Drugs stocks.

Psychoactive Drugs Stocks Recent News

Date Stock Title
May 1 MSOS Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision
May 1 YOLO Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision
May 1 MSOS Reclassifying Cannabis Still Leaves Pot Stocks in Limbo
May 1 MATV Axalta Coating Systems (AXTA) Tops Q1 Earnings and Revenue Estimates
May 1 SNDL SNDL Rallies On News Of U.S. Rescheduling Of Cannabis
Apr 30 MAPS Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
Apr 30 MSOS MSOS: Best Play On U.S. Cannabis Regulations
Apr 30 SNDL Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday
Apr 30 MSOS Cannabis industry: DEA reclassification is a 'critical first step'
Apr 30 MSOS Pot stocks surge on news of cannabis rescheduling
Apr 30 YOLO Pot stocks surge on news of cannabis rescheduling
Apr 30 YOLO DEA to reschedule marijuana as a less dangerous drug: AP
Apr 30 MSOS DEA to reschedule marijuana as a less dangerous drug: AP
Apr 30 MAPS 2024 Winners Unveiled for "Best of Weedmaps" Program
Apr 30 YOLO Marijuana rescheduling decision is imminent, anti-cannabis group says
Apr 30 MSOS Marijuana rescheduling decision is imminent, anti-cannabis group says
Apr 29 MNMD Psychedelic drug developers could benefit from NIH funding for chronic pain
Apr 29 CMPS Psychedelic drug developers could benefit from NIH funding for chronic pain
Apr 29 CLVR Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 KTTA Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Psychoactive Drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

Browse All Tags